Global Molecular Diagnostics For Sexually Transmitted Diseases Market Report 2025

Item added to cart!

Published : December 2025

Pages : 250

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00 $3367.00

Purchase This Report Download Sample PDF

Purchase This Report

Molecular Diagnostics For Sexually Transmitted Diseases Global Market Report 2025

Name: Molecular Diagnostics For Sexually Transmitted Diseases Global Market Report 2025
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

By Product (Instruments And Services, Consumables, Software), By Technology (Laboratory Testing, Point-Of-Care Testing), By Application (Chlamydia Trachomatis (CT) Or Neisseria Gonorrhoeae (NG) Testing, Syphilis Testing, Gonorrhea Testing, Herpes Simplex Virus (HSV) Testing, Human Papillomavirus (HPV) Testing, Human Immunodeficiency Virus (HIV) Testing, Trichomonas, Ureaplasma And Mycoplasma, Other Applications) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Molecular Diagnostics For Sexually Transmitted Diseases Market Overview

• Molecular Diagnostics For Sexually Transmitted Diseases market size has reached to $3.31 billion in 2024

• Expected to grow to $5.48 billion in 2029 at a compound annual growth rate (CAGR) of 10.5%

• Growth Driver: Rising Prevalence Of STIs Fueling The Growth Of The Market Due To Increasing Need For Early And Accurate Detection

• Market Trend: Innovation In Rapid Point-Of-Care PCR Devices Enhancing STI Diagnostic Accessibility And Efficiency

• North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Molecular Diagnostics For Sexually Transmitted Diseases Market?

Molecular diagnostics for sexually transmitted diseases involve techniques that detect the genetic material of infectious organisms, such as DNA or RNA, to identify the presence of pathogens. These methods are known for their high accuracy and sensitivity, enabling the detection of infections even when symptoms are not present. By analyzing the molecular structure of the pathogens, these diagnostics provide reliable identification, contributing to faster diagnosis.

The main product types of molecular diagnostics for sexually transmitted diseases include instruments and services, consumables, and software. Instruments refer to the diagnostic devices and platforms used for detecting pathogens, while services include laboratory testing, sample processing, and diagnostic result interpretation provided by healthcare or diagnostic companies. These diagnostics utilize various technologies such as laboratory testing and point-of-care Testing and are applied in a range of applications, including chlamydia trachomatis (CT) or neisseria gonorrhoeae (NG) testing, syphilis testing, gonorrhea testing, herpes simplex virus (HSV) testing, human papillomavirus (HPV) testing, human immunodeficiency virus (HIV) testing, trichomonas, ureaplasma and mycoplasma, and others.

Molecular Diagnostics For Sexually Transmitted Diseases Market Size and growth rate 2025 to 2029: Graph

What Is The Molecular Diagnostics For Sexually Transmitted Diseases Market Size 2025 And Growth Rate?

What Is The Molecular Diagnostics For Sexually Transmitted Diseases Market Growth Forecast?

The molecular diagnostics for sexually transmitted diseases market size is expected to see rapid growth in the next few years. It will grow to $5.48 billion in 2029 at a compound annual growth rate (CAGR) of 10.5%. The growth in the forecast period can be attributed to increasing focus on early disease detection, rising demand for personalized diagnostics, expansion of sexually transmitted infection surveillance programs, growing public-private partnerships, and rising preference for non-invasive testing methods. Major trends in the forecast period include technology advancements in molecular assay platforms, innovations in point-of-care diagnostic devices, development of multiplex polymerase chain reaction (PCR)-based testing panels, research and development in portable and automated systems, and integration of artificial intelligence in result interpretation.

Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Medical Equipment Industry?

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers’ margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

How Is The Molecular Diagnostics For Sexually Transmitted Diseases Market Segmented?

1) By Product: Instruments And Services, Consumables, Software

2) By Technology: Laboratory Testing, Point-Of-Care Testing

3) By Application: Chlamydia Trachomatis (CT) Or Neisseria Gonorrhoeae (NG) Testing, Syphilis Testing, Gonorrhea Testing, Herpes Simplex Virus (HSV) Testing, Human Papillomavirus (HPV) Testing, Human Immunodeficiency Virus (HIV) Testing, Trichomonas, Ureaplasma And Mycoplasma, Other Applications

Subsegment:

1) By Instruments And Services: Molecular Diagnostic Analyzers, Automated Polymerase Chain Reaction Systems, Nucleic Acid Extraction Instruments, Diagnostic Service Providers, Maintenance And Calibration Services, Installation And Training Services

2) By Consumables: Deoxyribonucleic Acid Extraction Kits, Ribonucleic Acid Extraction Kits, Polymerase Chain Reaction Reagents, Nucleic Acid Probes, Control And Reference Standards, Detection Enzymes And Buffers

3) By Software: Data Interpretation And Reporting Software, Polymerase Chain Reaction Workflow Management Software, Laboratory Information Management Systems, Diagnostic Decision Support Software, Quality Control Monitoring Software

What Is Driving The Molecular Diagnostics For Sexually Transmitted Diseases Market? Rising Prevalence Of STIs Fueling The Growth Of The Market Due To Increasing Need For Early And Accurate Detection

The rising prevalence of sexually transmitted infections is expected to propel the growth of the molecular diagnostics for sexually transmitted diseases market going forward. Sexually transmitted infections (STIs) refer to infections caused by bacteria, viruses, or parasites that are transmitted through sexual contact, affecting the reproductive and urinary systems. The prevalence of sexually transmitted infections is increasing primarily due to the inconsistent use of protection methods. This lack of protection facilitates the easier transmission of infections among sexually active individuals. Molecular diagnostics for sexually transmitted infections (STIs) play a critical role in managing these infections by enabling early and accurate detection of pathogens, even in asymptomatic individuals, facilitating timely treatment, reducing disease transmission, and improving overall patient outcomes. For instance, in January 2024, according to the National Association of County and City Health Officials (NACCHO), a US-based nonprofit organization, a total of 3,755 congenital syphilis cases were reported, marking a 31% rise between 2021 and 2022. Therefore, a rising prevalence of sexually transmitted infections is driving the growth of the molecular diagnostics for sexually transmitted diseases industry.

Who Are The Major Players In The Global Molecular Diagnostics For Sexually Transmitted Diseases Market?

Major companies operating in the molecular diagnostics for sexually transmitted diseases market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Illumina Inc., Hologic Inc., bioMérieux S.A., QuidelOrtho Corporation, QIAGEN N.V., Cepheid, Sansure Biotech Inc., OraSure Technologies Inc., Meridian Bioscience, Seegene Inc., Visby Medical Inc., Zeesan Biotech, Binx Health Inc., GCC Biotech, GeneProof, and Solone Life Sciences India (P) Ltd.

What Are The Key Trends Of The Global Molecular Diagnostics For Sexually Transmitted Diseases Market? Innovation In Rapid Point-Of-Care PCR Devices Enhancing STI Diagnostic Accessibility And Efficiency

Major companies operating in the molecular diagnostics for sexually transmitted diseases market are focusing on developing innovative solutions, such as rapid point-of-care polymerase chain reaction (PCR) devices, to improve diagnostic speed, accuracy, and accessibility. Rapid point-of-care polymerase chain reaction (PCR) devices are portable molecular diagnostic tools that combine sample preparation, amplification, and detection into a single, compact unit, enabling timely and highly sensitive pathogen detection outside traditional laboratory settings. For instance, in March 2025, Visby Medical, a US-based diagnostic technology company, launched the Visby Medical Women’s Sexual Health Test. The product is a single-use, handheld PCR device designed to identify chlamydia, gonorrhea, and trichomoniasis from vaginal samples within 30 minutes. It operates without the need for external instrumentation or cold-chain logistics, features an integrated amplification system, and provides lab-quality results directly at the point of care to support immediate clinical decisions. The test is authorized for prescription home use, making it the first U.S. Food and Drug Administration (FDA)-cleared molecular diagnostic test for multiple sexually transmitted infections (STIs) that can be used outside clinical settings. This launch reflects a shift toward decentralized diagnostic solutions that increase accessibility, especially in underserved or remote populations.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Molecular Diagnostics For Sexually Transmitted Diseases Market? OraSure Expands STI Molecular Diagnostics Through Sherlock Acquisition

In December 2024, OraSure Technologies, a US-based provider of point-of-care and home diagnostic solutions, acquired Sherlock Biosciences for an undisclosed amount. With this acquisition, OraSure aimed to expand its molecular diagnostics portfolio in sexual health by integrating Sherlock’s over-the-counter chlamydia trachomatis and neisseria gonorrhoeae self-test, which delivers laboratory-quality results in under 30 minutes using a clustered regularly interspaced short palindromic repeats-based and isothermal amplification-based platform. Sherlock Biosciences is a US-based biotechnology company specializing in molecular diagnostics for sexually transmitted diseases.

What Is The Regional Outlook For The Global Molecular Diagnostics For Sexually Transmitted Diseases Market?

North America was the largest region in the molecular diagnostics for sexually transmitted diseases market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Molecular Diagnostics For Sexually Transmitted Diseases Market?

The molecular diagnostics for sexually transmitted diseases market consists of revenues earned by entities by providing services such as test development, sample collection, nucleic acid amplification, and point of care diagnostics. The market value includes the value of related goods sold by the service provider or included within the service offering. The molecular diagnostics for sexually transmitted diseases market also includes sales of polymerase chain reaction kits, isothermal nucleic acid amplification kits, clustered regularly interspaced short palindromic repeats-based tests, and instrument-free molecular diagnostic systems. values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Molecular Diagnostics For Sexually Transmitted Diseases Industry?

The molecular diagnostics for sexually transmitted diseases market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the molecular diagnostics for sexually transmitted diseases industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Molecular Diagnostics For Sexually Transmitted Diseases Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$3.67 billion
Revenue Forecast In 2034	$5.48 billion
Growth Rate	CAGR of 10.5% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	Product, Technology, Application, Instruments And Services, Consumables, Software
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Illumina Inc., Hologic Inc., bioMérieux S.A., QuidelOrtho Corporation, QIAGEN N.V., Cepheid, Sansure Biotech Inc., OraSure Technologies Inc., Meridian Bioscience, Seegene Inc., Visby Medical Inc., Zeesan Biotech, Binx Health Inc., GCC Biotech, GeneProof, and Solone Life Sciences India (P) Ltd.
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Molecular Diagnostics For Sexually Transmitted Diseases Market Characteristics

3. Molecular Diagnostics For Sexually Transmitted Diseases Market Trends And Strategies

4. Molecular Diagnostics For Sexually Transmitted Diseases Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Molecular Diagnostics For Sexually Transmitted Diseases Growth Analysis And Strategic Analysis Framework

5.1. Global Molecular Diagnostics For Sexually Transmitted Diseases PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Molecular Diagnostics For Sexually Transmitted Diseases Market Growth Rate Analysis

5.4. Global Molecular Diagnostics For Sexually Transmitted Diseases Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Molecular Diagnostics For Sexually Transmitted Diseases Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Molecular Diagnostics For Sexually Transmitted Diseases Total Addressable Market (TAM)

6. Molecular Diagnostics For Sexually Transmitted Diseases Market Segmentation

6.1. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Instruments And Services

Consumables

Software

6.2. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Laboratory Testing

Point-Of-Care Testing

6.3. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Chlamydia Trachomatis (CT) Or Neisseria Gonorrhoeae (NG) Testing

Syphilis Testing

Gonorrhea Testing

Herpes Simplex Virus (HSV) Testing

Human Papillomavirus (HPV) Testing

Human Immunodeficiency Virus (HIV) Testing

Trichomonas

Ureaplasma And Mycoplasma

Other Applications

6.4. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, Sub-Segmentation Of Instruments And Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Molecular Diagnostic Analyzers

Automated Polymerase Chain Reaction Systems

Nucleic Acid Extraction Instruments

Diagnostic Service Providers

Maintenance And Calibration Services

Installation And Training Services

6.5. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, Sub-Segmentation Of Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Deoxyribonucleic Acid Extraction Kits

Ribonucleic Acid Extraction Kits

Polymerase Chain Reaction Reagents

Nucleic Acid Probes

Control And Reference Standards

Detection Enzymes And Buffers

6.6. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, Sub-Segmentation Of Softwares, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Data Interpretation And Reporting Software

Polymerase Chain Reaction Workflow Management Software

Laboratory Information Management Systems

Diagnostic Decision Support Software

Quality Control Monitoring Software

7. Molecular Diagnostics For Sexually Transmitted Diseases Market Regional And Country Analysis

7.1. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Molecular Diagnostics For Sexually Transmitted Diseases Market

8.1. Asia-Pacific Molecular Diagnostics For Sexually Transmitted Diseases Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Molecular Diagnostics For Sexually Transmitted Diseases Market

9.1. China Molecular Diagnostics For Sexually Transmitted Diseases Market Overview

9.2. China Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Molecular Diagnostics For Sexually Transmitted Diseases Market

10.1. India Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Molecular Diagnostics For Sexually Transmitted Diseases Market

11.1. Japan Molecular Diagnostics For Sexually Transmitted Diseases Market Overview

11.2. Japan Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Molecular Diagnostics For Sexually Transmitted Diseases Market

12.1. Australia Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Molecular Diagnostics For Sexually Transmitted Diseases Market

13.1. Indonesia Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Molecular Diagnostics For Sexually Transmitted Diseases Market

14.1. South Korea Molecular Diagnostics For Sexually Transmitted Diseases Market Overview

14.2. South Korea Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Molecular Diagnostics For Sexually Transmitted Diseases Market

15.1. Western Europe Molecular Diagnostics For Sexually Transmitted Diseases Market Overview

15.2. Western Europe Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Molecular Diagnostics For Sexually Transmitted Diseases Market

16.1. UK Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Molecular Diagnostics For Sexually Transmitted Diseases Market

17.1. Germany Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Molecular Diagnostics For Sexually Transmitted Diseases Market

18.1. France Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Molecular Diagnostics For Sexually Transmitted Diseases Market

19.1. Italy Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Molecular Diagnostics For Sexually Transmitted Diseases Market

20.1. Spain Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Molecular Diagnostics For Sexually Transmitted Diseases Market

21.1. Eastern Europe Molecular Diagnostics For Sexually Transmitted Diseases Market Overview

21.2. Eastern Europe Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Molecular Diagnostics For Sexually Transmitted Diseases Market

22.1. Russia Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Molecular Diagnostics For Sexually Transmitted Diseases Market

23.1. North America Molecular Diagnostics For Sexually Transmitted Diseases Market Overview

23.2. North America Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Molecular Diagnostics For Sexually Transmitted Diseases Market

24.1. USA Molecular Diagnostics For Sexually Transmitted Diseases Market Overview

24.2. USA Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Molecular Diagnostics For Sexually Transmitted Diseases Market

25.1. Canada Molecular Diagnostics For Sexually Transmitted Diseases Market Overview

25.2. Canada Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Molecular Diagnostics For Sexually Transmitted Diseases Market

26.1. South America Molecular Diagnostics For Sexually Transmitted Diseases Market Overview

26.2. South America Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Molecular Diagnostics For Sexually Transmitted Diseases Market

27.1. Brazil Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Molecular Diagnostics For Sexually Transmitted Diseases Market

28.1. Middle East Molecular Diagnostics For Sexually Transmitted Diseases Market Overview

28.2. Middle East Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Molecular Diagnostics For Sexually Transmitted Diseases Market

29.1. Africa Molecular Diagnostics For Sexually Transmitted Diseases Market Overview

29.2. Africa Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Molecular Diagnostics For Sexually Transmitted Diseases Market Competitive Landscape And Company Profiles

30.1. Molecular Diagnostics For Sexually Transmitted Diseases Market Competitive Landscape

30.2. Molecular Diagnostics For Sexually Transmitted Diseases Market Company Profiles

30.2.1. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Molecular Diagnostics For Sexually Transmitted Diseases Market Other Major And Innovative Companies

31.1. Hologic Inc.

31.2. bioMérieux S.A.

31.3. QuidelOrtho Corporation

31.4. QIAGEN N.V.

31.5. Cepheid

31.6. Sansure Biotech Inc.

31.7. OraSure Technologies Inc.

31.8. Meridian Bioscience

31.9. Seegene Inc.

31.10. Visby Medical Inc.

31.11. Zeesan Biotech

31.12. Binx Health Inc.

31.13. GCC Biotech

31.14. GeneProof

31.15. Solone Life Sciences India (P) Ltd.

32. Global Molecular Diagnostics For Sexually Transmitted Diseases Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Molecular Diagnostics For Sexually Transmitted Diseases Market

34. Recent Developments In The Molecular Diagnostics For Sexually Transmitted Diseases Market

35. Molecular Diagnostics For Sexually Transmitted Diseases Market High Potential Countries, Segments and Strategies

35.1 Molecular Diagnostics For Sexually Transmitted Diseases Market In 2029 - Countries Offering Most New Opportunities

35.2 Molecular Diagnostics For Sexually Transmitted Diseases Market In 2029 - Segments Offering Most New Opportunities

35.3 Molecular Diagnostics For Sexually Transmitted Diseases Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Molecular Diagnostics For Sexually Transmitted Diseases Market, Sub-Segmentation Of Instruments And Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Molecular Diagnostics For Sexually Transmitted Diseases Market, Sub-Segmentation Of Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Molecular Diagnostics For Sexually Transmitted Diseases Market, Sub-Segmentation Of Softwares, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Molecular Diagnostics For Sexually Transmitted Diseases Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Molecular Diagnostics For Sexually Transmitted Diseases Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Asia-Pacific, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Asia-Pacific, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Asia-Pacific, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: China, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: China, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: China, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: India, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: India, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: India, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: Japan, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: Japan, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Japan, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Australia, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Australia, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Australia, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Indonesia, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Indonesia, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Indonesia, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: South Korea, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: South Korea, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: South Korea, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: Western Europe, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: Western Europe, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Western Europe, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: UK, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: UK, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: UK, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: Germany, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: Germany, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: Germany, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: France, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: France, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: France, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: Italy, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: Italy, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: Italy, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Spain, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Spain, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Spain, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Eastern Europe, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Eastern Europe, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Eastern Europe, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Russia, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Russia, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Russia, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: North America, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: North America, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: North America, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: USA, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: USA, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: USA, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: Canada, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: Canada, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: Canada, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: South America, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: South America, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: South America, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: Brazil, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: Brazil, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: Brazil, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Middle East, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Middle East, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Middle East, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Africa, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Africa, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Africa, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: F. Hoffmann-La Roche Ltd Financial Performance

Table 78: Thermo Fisher Scientific Inc. Financial Performance

Table 79: Abbott Laboratories Financial Performance

Table 80: Siemens Healthineers AG Financial Performance

Table 81: Illumina Inc. Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Molecular Diagnostics For Sexually Transmitted Diseases Market, Sub-Segmentation Of Instruments And Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Molecular Diagnostics For Sexually Transmitted Diseases Market, Sub-Segmentation Of Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Molecular Diagnostics For Sexually Transmitted Diseases Market, Sub-Segmentation Of Softwares, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Molecular Diagnostics For Sexually Transmitted Diseases Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Molecular Diagnostics For Sexually Transmitted Diseases Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Asia-Pacific, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Asia-Pacific, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Asia-Pacific, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: China, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: China, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: China, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: India, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: India, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: India, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: Japan, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: Japan, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Japan, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Australia, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Australia, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Australia, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Indonesia, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Indonesia, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Indonesia, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: South Korea, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: South Korea, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: South Korea, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: Western Europe, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: Western Europe, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Western Europe, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: UK, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: UK, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: UK, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: Germany, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: Germany, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: Germany, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: France, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: France, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: France, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: Italy, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: Italy, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: Italy, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Spain, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Spain, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Spain, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Eastern Europe, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Eastern Europe, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Eastern Europe, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Russia, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Russia, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Russia, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: North America, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: North America, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: North America, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: USA, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: USA, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: USA, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: Canada, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: Canada, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: Canada, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: South America, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: South America, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: South America, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: Brazil, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: Brazil, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: Brazil, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Middle East, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Middle East, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Middle East, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Africa, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Africa, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Africa, Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: F. Hoffmann-La Roche Ltd Financial Performance

Figure 78: Thermo Fisher Scientific Inc. Financial Performance

Figure 79: Abbott Laboratories Financial Performance

Figure 80: Siemens Healthineers AG Financial Performance

Figure 81: Illumina Inc. Financial Performance

Gait Analyzer Market Forecast 2025–2034: Trends Reshaping Demand, Investment, and Innovation

Global Gynecology Surgical Forceps Market Projected to Reach $16.54 Billion by 2029 at a CAGR of 6.3%

$11.02 Billion Forecast for Healthcare Mobile Robots Market by 2029, Backed by Demand and Innovation

Heart Defect Closure Device Market Forecast Reaching $2.12 Billion by 2029 at 13.7% CAGR

Discover the latest insights, trends, and market numbers in the maternal and baby grade wipes market backed by expert analysis and data-driven projections.

Discover the latest insights, trends, and market numbers in the medical soap market backed by expert analysis and data-driven projections.

Discover the latest insights, trends, and market numbers in the lichen planus market backed by expert analysis and data-driven projections.

Explore strategic insights and forecasts in the global virtual biopsy market, offering competitive benchmarking and market growth trends.

Trade Credit Insurance Global Market Report 2025 – By Component (Product, Services), By Coverages (Whole Turnover Coverage, Single Buyer Coverage), By Application (Domestic, Exports), By Industry Vertical (Food and Bever...

Household Insecticides Global Market Report 2025 – By Product( Sprays, Vaporizers, Mosquito Coils, Baits, Other Products), By Type( Mosquito And Fly Control, Rodent Control, Termite Control, Bedbugs And Beetle Control, O...

Household Lending Global Market Report 2025 – By Types (Fixed Rate Loans, Home Equity Line of Credit), By Service Providers (Banks, Online, Credit Union, Other Service Providers), By Source (Mortgage and Credit Union, Co...

Insurance Global Market Report 2025 – By Type (Life Insurance, Property And Casualty Insurance, Health And Medical Insurance), By Mode (Online, Offline), By End User (Corporate, Individual) – Impact of Tariff and Trade W...

Home Insurance Global Market Report 2025 – By Coverage (Dwelling Coverage, Content Coverage, Liability Coverage Banking, Other Coverages), By Provider (Insurance Companies, Insurance Agents Or Brokers, Other Providers), ...

Debt Financing Global Market Report 2025 – By Sources (Private, Public), By Type (Bank Loans, Bonds, Debenture, Bearer Bond, Other Types), By Duration (Short-Term, Long-Term) – Impact of Tariff and Trade War on Market Si...

Loan Brokers Global Market Report 2025 – By Component (Products, Services), By Enterprise Size (Large Enterprise, Small And Medium-Sized Enterprises), By Application (Home Loans, Commercial And Industrial Loans, Vehicle ...

Frequently Asked Questions

What is the definition of the Molecular Diagnostics For Sexually Transmitted Diseases market?

How will the Molecular Diagnostics For Sexually Transmitted Diseases market drivers and restraints affect the market dynamics? What forces will shape the Molecular Diagnostics For Sexually Transmitted Diseases industry going forward?

The market major growth driver - Rising Prevalence Of STIs Fueling The Growth Of The Market Due To Increasing Need For Early And Accurate Detection. For further insights on this market, request a sample here

What is the forecast market size or the forecast market value of the Molecular Diagnostics For Sexually Transmitted Diseases market?

The molecular diagnostics for sexually transmitted diseases market size has grown rapidly in recent years. It will grow from $3.31 billion in 2024 to $3.67 billion in 2025 at a compound annual growth rate (CAGR) of 10.9%. The growth in the historic period can be attributed to rising prevalence of sexually transmitted infections, increasing use of nucleic acid amplification tests, growing awareness through government screening programs, support from global health organizations, and early adoption in diagnostic laboratories. The molecular diagnostics for sexually transmitted diseases market size is expected to see rapid growth in the next few years. It will grow to $5.48 billion in 2029 at a compound annual growth rate (CAGR) of 10.5%. The growth in the forecast period can be attributed to increasing focus on early disease detection, rising demand for personalized diagnostics, expansion of sexually transmitted infection surveillance programs, growing public-private partnerships, and rising preference for non-invasive testing methods. Major trends in the forecast period include technology advancements in molecular assay platforms, innovations in point-of-care diagnostic devices, development of multiplex polymerase chain reaction (PCR)-based testing panels, research and development in portable and automated systems, and integration of artificial intelligence in result interpretation. For further insights on this market, request a sample here

How is the Molecular Diagnostics For Sexually Transmitted Diseases market segmented?

The molecular diagnostics for sexually transmitted diseases market covered in this report is segmented
1) By Product: Instruments And Services, Consumables, Software
2) By Technology: Laboratory Testing, Point-Of-Care Testing
3) By Application: Chlamydia Trachomatis (CT) Or Neisseria Gonorrhoeae (NG) Testing, Syphilis Testing, Gonorrhea Testing, Herpes Simplex Virus (HSV) Testing, Human Papillomavirus (HPV) Testing, Human Immunodeficiency Virus (HIV) Testing, Trichomonas, Ureaplasma And Mycoplasma, Other Applications Subsegment:
1) By Instruments And Services: Molecular Diagnostic Analyzers, Automated Polymerase Chain Reaction Systems, Nucleic Acid Extraction Instruments, Diagnostic Service Providers, Maintenance And Calibration Services, Installation And Training Services
2) By Consumables: Deoxyribonucleic Acid Extraction Kits, Ribonucleic Acid Extraction Kits, Polymerase Chain Reaction Reagents, Nucleic Acid Probes, Control And Reference Standards, Detection Enzymes And Buffers
3) By Software: Data Interpretation And Reporting Software, Polymerase Chain Reaction Workflow Management Software, Laboratory Information Management Systems, Diagnostic Decision Support Software, Quality Control Monitoring Software For further insights on this market, request a sample here

Which region has the largest share of the Molecular Diagnostics For Sexually Transmitted Diseases market? What are the other regions covered in the report?

North America was the largest region in the molecular diagnostics for sexually transmitted diseases market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the molecular diagnostics for sexually transmitted diseases market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Who are the major players in the Molecular Diagnostics For Sexually Transmitted Diseases market?

What are the key trends in the Molecular Diagnostics For Sexually Transmitted Diseases market?

Major trends in this market include Innovation In Rapid Point-Of-Care PCR Devices Enhancing STI Diagnostic Accessibility And Efficiency. For further insights on this market, request a sample here.